Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluator-blinded randomized study of Neuramis Deep for correction of lip and perioral wrinkles
TCTR20231008002Phase 0Unknown
- Sponsor
- Medyceles
- Start
- Nov 2023
- Countries
- 1
01
Overview
Phase 0, randomised, single-blind trial of Neuramis Deep in Perioral lines (2 arms), sponsored by Medyceles. Primary endpoints: Effectiveness of Neuramis Deep for correction of lip and perioral wrinkles and Safety of Neuramis Deep. Status: unknown.
02
Drugs
Neuramis Deep
03
Conditions
Perioral lines
Beyond the preview
Go deeper on TCTR20231008002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231008002.